A Study to Assess the Acute Effects of Vildagliptin on Gastric Emptying in Patients With Type 2...
Diabetes MellitusType 2Please note this study is not being conducted in the United States. The purpose of this study is to assess the acute effects of vildagliptin, an unapproved drug, in reducing post-meal glucose levels by delaying gastric emptying.
Rosiglitazone-Metformin Combination Versus Metformin-Sulfonylurea Combination On Beta-Cell Function...
Type 2 Diabetes MellitusIt has been shown in previous study that progressive glycemic deterioration was associated with progressive loss of b-cell function, measured by the decrease in plasma insulin levels, irrespective of the therapy used (diet, sulfonylureas or metformin).There is growing evidence that thiazolidinediones could have a positive action on the b-cell function. But it has not yet been demonstrated that they could protect from a deterioration in insulin secretion in the long term. So, it appears interesting to study the long term evolution of the b-cell function and the possible protection with rosiglitazone in patients with type 2 diabetes showing evidence of loss of b-cell function with metformin alone.
Comparison of Exenatide Taken Before Lunch and Dinner With Before Breakfast and Dinner in Patients...
Type 2 DiabetesThis trial is designed to compare the effects of twice-daily (before lunch and before dinner) exenatide plus oral antidiabetic (OAD) agents and twice-daily (before breakfast and before dinner) exenatide plus OAD with respect to glycemic control (HbA1c) in patients with type 2 diabetes.
Study Comparing Pitavastatin and Atorvastatin in Patients With Type II Diabetes Mellitus and Combined...
Type II Diabetes MellitusDyslipidemiaThe purpose of this study is to compare the efficacy and safety of pitavastatin with that of atorvastatin in patients with type II diabetes mellitus (type II DM) and combined dyslipidemia.
Insulin Glulisine in Type 2 Diabetes Mellitus
Type 2 Diabetes MellitusPrimary objective: To compare the pharmacodynamics of insulin glulisine and insulin lispro injected subcutaneously before three 500 kcal standard meals during a 12 hour day, in obese subjects with type 2 diabetes. Secondary objectives: To compare the pharmacokinetics of insulin glulisine and insulin lispro in obese subjects with type 2 diabetes, injected subcutaneously before three standard meals during a 12-hour day. The safety of insulin glulisine, the relationship of the pharmacodynamics and pharmacokinetics with skin thickness and C-peptide, non-esterified fatty acid, triglyceride and β-hydroxybutyrate levels in these subjects will also be assessed.
Study of Alogliptin Combined With Pioglitazone in Subjects With Type 2 Diabetes Mellitus
Diabetes MellitusThe purpose of this study is to evaluate the efficacy and safety of alogliptin, once daily (QD), combined with pioglitazone in adults with type 2 diabetes mellitus
GSK189075, GW869682 Or Placebo In Type 2 Diabetic Patients
Diabetes MellitusType 21 moreThis is a study to compare the safety, blood concentrations, and effects of GSK189075, GW869682, and placebo when dosed for 2-weeks by mouth to patients with type 2 diabetes.
MK0431 Monotherapy Study in Patients With Type 2 Diabetes Mellitus (0431-040)
Type 2 Diabetes MellitusThis is a clinical study to determine the safety and efficacy of an investigational drug in patients with type 2 diabetes mellitus.
Ambulatory Blood Pressure Reduction After Rosiglitazone Treatment In Normotensive Type 2 Diabetic...
Diabetes MellitusType 2The purpose of this study was to determine the effects of rosiglitazone in normotensive type 2 diabetic patients with regard to its blood-pressure-reducing effects.
MK-0431 Early Phase II Double-blind Study - Type 2 Diabetes Mellitus (0431-043)
Type 2 Diabetes MellitusA clinical study to determine the safety and efficacy of MK-0431 in patients with Type 2 diabetes mellitus who have inadequate glycemic control on diet/exercise therapy